Fig. 7.
Monitoring of EBV-DNA load in patients 7, 8, and 9.
Patients 7 and 8, a 15-year-old boy with SAA and an 11-year-old girl with ALL, respectively, received unmanipulated bone marrow from HLA-identical unrelated donors. Patient 9, an 8-year-old girl with thalassemia, received unmanipulated marrow from an HLA-matched sibling. The posttransplant course was uncomplicated with no GVHD in all 3 patients. * EBV-DNA was not detected in the DNA equivalent of 105 cells.
